Olive Tree Capital

What is Olive Tree Capital?

Olive Tree Capital is a Los Angeles-based investment firm that serves as the foreign investment arm of a single member family office, engaging in seed, early stage, and later stage investments.

They position themselves as investors in groundbreaking technology and life sciences companies, committing to entrepreneurs who share a vision for a better future and embody a deep sense of passion and commitment to their ventures. They abide by the Golden Rule in all business dealings, which hints at ethical practices and mutual respect in their investment due diligence and partner relationships.

With a strong emphasis on building a future-oriented portfolio, Olive Tree Capital is selective in investing in healthcare and life sciences, as well as in various frontier technologies. Their investment range is set at a minimum and maximum of $11,000,000, potentially indicating a focused approach to funding companies when they do invest rather than spreading resources thinly across multiple ventures.

The firm's portfolio reflects a diverse array of sectors, including healthcare and life sciences, financial technologies, consumer services, enterprise solutions, AI/ML (artificial intelligence/machine learning), and blockchain. This breadth of interests demonstrates a dedication to fostering innovation across a variety of industries. Companies that have received investment from Olive Tree Capital include those working on challenges such as new drug development, biotherapeutics, medical diagnostics, AI-driven healthcare solutions, financial technology platforms, and consumer-centric services.

The firm clearly believes in supporting companies that have potential for significant impact and growth in their respective fields. In doing so, Olive Tree Capital actively participates in the growth trajectory of these companies, from early stages through to growth and potential exit opportunities, and in some cases, until the company exits or reaches substantial stages of development.